Literature DB >> 12413928

The genetics of ovarian cancer.

Paul D P Pharoah1, Bruce A J Ponder.   

Abstract

A family history of ovarian cancer confers an increased risk of ovarian cancer. We review the literature quantifying the familial risks associated with ovarian cancer and assess the evidence that the familial clustering of ovarian cancer is genetically determined. We then describe the known high-penetrance genes, the ovarian cancer risks attached to them and their contribution to ovarian cancer in families and in the general population. The evidence for the existence of other ovarian cancer genes is then considered.

Entities:  

Mesh：

Year:  2002        PMID： 12413928     DOI： 10.1053/beog.2002.0296

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN： 1521-6934            Impact factor:   5.237


  22 in total

1.  Factors affecting frequency of communication about family health history with family members and doctors in a medically underserved population.

Authors:  Kimberly A Kaphingst; Melody Goodman; Chintan Pandya; Priyanka Garg; Jewel Stafford; Christina Lachance
Journal:  Patient Educ Couns       Date:  2011-12-23

2.  Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.

Authors:  Ana Krivokuca; Vita Setrajcic Dragos; Ljiljana Stamatovic; Ana Blatnik; Ivana Boljevic; Vida Stegel; Jelena Rakobradovic; Petra Skerl; Stevo Jovandic; Mateja Krajc; Mirjana Brankovic Magic; Srdjan Novakovic
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

3.  Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.

Authors:  Kristin L White; Thomas A Sellers; Brooke L Fridley; Robert A Vierkant; Catherine M Phelan; Ya-Yu Tsai; Kimberly R Kalli; Andrew Berchuck; Edwin S Iversen; Lynn C Hartmann; Mark Liebow; Sebastian Armasu; Zachary Fredericksen; Melissa C Larson; David Duggan; Fergus J Couch; Joellen M Schildkraut; Julie M Cunningham; Ellen L Goode
Journal:  Twin Res Hum Genet       Date:  2010-02       Impact factor: 1.587

4.  Primary care physician management, referral, and relations with specialists concerning patients at risk for cancer due to family history.

Authors:  M E Wood; B S Flynn; A Stockdale
Journal:  Public Health Genomics       Date:  2013-01-17       Impact factor: 2.000

5.  Risk of ovarian cancer and inherited variants in relapse-associated genes.

Authors:  Abraham Peedicayil; Robert A Vierkant; Lynn C Hartmann; Brooke L Fridley; Zachary S Fredericksen; Kristin L White; Elaine A Elliott; Catherine M Phelan; Ya-Yu Tsai; Andrew Berchuck; Edwin S Iversen; Fergus J Couch; Prema Peethamabaran; Melissa C Larson; Kimberly R Kalli; Matthew L Kosel; Vijayalakshmi Shridhar; David N Rider; Mark Liebow; Julie M Cunningham; Joellen M Schildkraut; Thomas A Sellers; Ellen L Goode
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

6.  Interviews with primary care physicians regarding taking and interpreting the cancer family history.

Authors:  Marie E Wood; Alan Stockdale; Brian S Flynn
Journal:  Fam Pract       Date:  2008-09-01       Impact factor: 2.267

7.  Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.

Authors:  Sharon E Johnatty; Jonathan Beesley; Xiaoqing Chen; Amanda B Spurdle; Anna Defazio; Penelope M Webb; Ellen L Goode; David N Rider; Robert A Vierkant; Stephanie Anderson; Anna H Wu; Malcolm Pike; David Van Den Berg; Kirsten Moysich; Roberta Ness; Jennifer Doherty; Mary-Anne Rossing; Celeste Leigh Pearce; Georgia Chenevix-Trench
Journal:  Twin Res Hum Genet       Date:  2009-06       Impact factor: 1.587

8.  A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

Authors:  Honglin Song; Susan J Ramus; Jonathan Tyrer; Kelly L Bolton; Aleksandra Gentry-Maharaj; Eva Wozniak; Hoda Anton-Culver; Jenny Chang-Claude; Daniel W Cramer; Richard DiCioccio; Thilo Dörk; Ellen L Goode; Marc T Goodman; Joellen M Schildkraut; Thomas Sellers; Laura Baglietto; Matthias W Beckmann; Jonathan Beesley; Jan Blaakaer; Michael E Carney; Stephen Chanock; Zhihua Chen; Julie M Cunningham; Ed Dicks; Jennifer A Doherty; Matthias Dürst; Arif B Ekici; David Fenstermacher; Brooke L Fridley; Graham Giles; Martin E Gore; Immaculata De Vivo; Peter Hillemanns; Claus Hogdall; Estrid Hogdall; Edwin S Iversen; Ian J Jacobs; Anna Jakubowska; Dong Li; Jolanta Lissowska; Jan Lubiński; Galina Lurie; Valerie McGuire; John McLaughlin; Krzysztof Medrek; Patricia G Moorman; Kirsten Moysich; Steven Narod; Catherine Phelan; Carole Pye; Harvey Risch; Ingo B Runnebaum; Gianluca Severi; Melissa Southey; Daniel O Stram; Falk C Thiel; Kathryn L Terry; Ya-Yu Tsai; Shelley S Tworoger; David J Van Den Berg; Robert A Vierkant; Shan Wang-Gohrke; Penelope M Webb; Lynne R Wilkens; Anna H Wu; Hannah Yang; Wendy Brewster; Argyrios Ziogas; Richard Houlston; Ian Tomlinson; Alice S Whittemore; Mary Anne Rossing; Bruce A J Ponder; Celeste Leigh Pearce; Roberta B Ness; Usha Menon; Susanne Krüger Kjaer; Jacek Gronwald; Montserrat Garcia-Closas; Peter A Fasching; Douglas F Easton; Georgia Chenevix-Trench; Andrew Berchuck; Paul D P Pharoah; Simon A Gayther
Journal:  Nat Genet       Date:  2009-08-02       Impact factor: 38.330

9.  Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.

Authors:  Marie E Wood; Pamela Kadlubek; Trang H Pham; Dana S Wollins; Karen H Lu; Jeffrey N Weitzel; Michael N Neuss; Kevin S Hughes
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

10.  Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.

Authors:  Honglin Song; Susan J Ramus; Susanne Krüger Kjaer; Richard A DiCioccio; Georgia Chenevix-Trench; Celeste Leigh Pearce; Estrid Hogdall; Alice S Whittemore; Valerie McGuire; Claus Hogdall; Jan Blaakaer; Anna H Wu; David J Van Den Berg; Daniel O Stram; Usha Menon; Aleksandra Gentry-Maharaj; Ian J Jacobs; Penny M Webb; Jonathan Beesley; Xiaoqing Chen; Mary Anne Rossing; Jennifer A Doherty; Jenny Chang-Claude; Shan Wang-Gohrke; Marc T Goodman; Galina Lurie; Pamela J Thompson; Michael E Carney; Roberta B Ness; Kirsten Moysich; Ellen L Goode; Robert A Vierkant; Julie M Cunningham; Stephanie Anderson; Joellen M Schildkraut; Andrew Berchuck; Edwin S Iversen; Patricia G Moorman; Montserrat Garcia-Closas; Stephen Chanock; Jolanta Lissowska; Louise Brinton; Hoda Anton-Culver; Argyrios Ziogas; Wendy R Brewster; Bruce A J Ponder; Douglas F Easton; Simon A Gayther; Paul D P Pharoah
Journal:  Hum Mol Genet       Date:  2009-03-20       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.